{
    "code": "02023749",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023749",
    "time": "2023-04-14 05:34:08",
    "許可證字號": "衛署藥輸字第023749號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "117\/06\/16",
    "發證日期": "92\/06\/16",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202374900",
    "中文品名": "益滿治 注射劑１公克",
    "英文品名": "INVANZ 1G INJECTION",
    "適應症": "INVANZ適用於治療病患由具感受性之微生物所引起的中度至重度感染，而且適用於下列感染在尚未鑑定出病原菌之前按經驗的治療處理(EMPIRIC THERAPY)：1.複雜的腹腔內感染 2.複雜的皮膚和皮膚組織感染 3.感染性肺炎(COMMUNITY ACQUIRED PNEUMONIA) 4.複雜的尿道感染，包括腎盂腎炎 5.急性骨盆感染，包括產後子宮內肌炎、敗血性流產和手術後婦科感染。",
    "劑型": "243凍晶注射劑",
    "包裝": "１公克小瓶 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ERTAPENEM SODIUM",
    "限制項目": "02輸　入 54依本署89、12、12衛署藥字第0890035812號公告事項九得免除國內進行臨床試驗之特殊醫療需要之新藥",
    "申請商名稱": "0929301100  美商默沙東藥廠股份有限公司台灣分公司",
    "申請商地址": "台北市信義區信義路五段106號12樓",
    "主製造廠": [
        {
            "製造廠名稱": "FFR0414000  FAREVA Mirabel",
            "製造廠廠址": "ROUTE DE MARSAT 63203 RIOM,FRANCE(ACTUAL ADDRESS) ROUTE DE MARSAT RIOM 63963 CLERMONT-FERRAND CEDEX 9,FRANCE(POSTAL-BOX)",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": ""
        }
    ],
    "CCC號列": "30042000916 人用醫藥製劑，含有其他抗生素者Medicaments, containing other antibiotics, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812002610",
            "成分名稱": "ERTAPENEM SODIUM",
            "含量描述": "",
            "含量": "1046.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Invanz_實體外觀-105-10-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023749&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "239937_chilab-02-CRT-MK0826-000021328-TW-PI-I-encephalopathy-pm-111-04-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023749&Seq=021&Type=9"
        },
        {
            "title": "TFDA_7003833000-150316-1-A01_Invanz_label-110-06-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023749&Seq=008&Type=8"
        },
        {
            "title": "TFDA_518812T-070714-1-A01 _Invanz_Carton-110-06-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023749&Seq=007&Type=8"
        }
    ]
}